Neoimmunetech Inc DRC (950220)

Currency in KRW
1,750
+62(+3.67%)
Closed·
950220 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,6771,764
52 wk Range
3673,705
Key Statistics
Bid/Ask
1,735.00 / 1,736.00
Prev. Close
1,750
Open
1,690
Day's Range
1,677-1,764
52 wk Range
367-3,705
Volume
88.22K
Average Volume (3m)
962.24K
1-Year Change
203.2929%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
950220 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

Earnings

Latest Release
12/08/2026
EPS / Forecast
-11.80 / --
Revenue / Forecast
1.17B / --
EPS Revisions
Last 90 days

950220 Income Statement

Compare 950220 to Peers and Sector

Metrics to compare
950220
Peers
Sector
Relationship
P/E Ratio
−7.1x−2.7x−0.3x
PEG Ratio
−0.11−0.070.00
Price/Book
3.1x1.3x2.6x
Price / LTM Sales
98.3x4.7x2.9x
Upside (Analyst Target)
-566.2%67.1%
Fair Value Upside
Unlock20.7%9.9%Unlock

NeoImmuneTech, Inc., a clinical-stage T cell-based biotechnology company, develops and sells immuno-therapeutics in Korea. It is developing NT-I7, an IL-7 class T- cell amplifier to treat acute radiation syndrome; and Heterodimer hybrid Fc platform, an antibody platform technology, as well as NT2020, a T cell activator; NT3020, a T cell engager; NT4010, an advanced CAR-T; and NT5010, a TME modifier. The company was incorporated in 2014 and is headquartered in Rockville, Maryland.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
6.69M6.77%11.71B
Public Companies & Retail Investors
92.18M93.23%161.31B
Total
98.87M100.00%173.02B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Genexine, Inc.6.77%6,689,67411,706,930

FAQ

What Is the Neoimmunetech DRC (950220) Stock Price Today?

The Neoimmunetech DRC stock price today is 1,750 KRW.

What Stock Exchange Does Neoimmunetech DRC Trade On?

Neoimmunetech DRC is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Neoimmunetech DRC?

The stock symbol for Neoimmunetech DRC is "950220."

What Is the Neoimmunetech DRC Market Cap?

As of today, Neoimmunetech DRC market cap is 173.02B KRW.

What Is Neoimmunetech DRC's Earnings Per Share (TTM)?

The Neoimmunetech DRC EPS (TTM) is -196.21.

From a Technical Analysis Perspective, Is 950220 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Neoimmunetech DRC Stock Split?

Neoimmunetech DRC has split 1 times.

How Many Employees Does Neoimmunetech DRC Have?

Neoimmunetech DRC has 52 employees.

What is the current trading status of Neoimmunetech DRC (950220)?

As of 18/10/2026, Neoimmunetech DRC (950220) is trading at a price of 1,750 KRW, with a previous close of 1,750 KRW. The stock has fluctuated within a day range of 1,677 KRW to 1,764 KRW, while its 52-week range spans from 367 KRW to 3,705 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.